New Zealand remains concerned over animal health merger

New Zealand’s antitrust watchdog has reiterated its concerns that animal health company Zoetis’ proposed acquisition of Jurox will harm competition for certain pre-anesthetics and sedatives for cats and dogs.

Get unlimited access to all Global Competition Review content